Search

Your search keyword '"Nadal, E."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Nadal, E." Remove constraint Author: "Nadal, E." Language undetermined Remove constraint Language: undetermined
37 results on '"Nadal, E."'

Search Results

1. Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC-a systematic review and meta-analysis

2. Pre-treatment tissue TCR repertoire evenness is associated with complete pathological response in patients with NSCLC receiving neoadjuvant chemoimmunotherapy

7. Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors

8. Somatic Genome Alterations in Lung Cancer Patients Diagnosed with Li Fraumeni Syndrome

9. Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases

11. Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition

14. A Synthetic Multicellular Memory Device

21. Error estimation and error bounding in quantities of interest based on equilibrated recovered displacement fields

24. New antiherpetic 1,3-phenylene derivatives, inhibitors of the interaction of the HSV-1 origin binding protein (OBP) with DNA

25. Synthesis and evaluation of new Reissert analogs as HIV-1 RT inhibitors. 2. Benzo[f]quinoline and pyridine derivatives

29. A novel epigenetic signature for early diagnosis in lung cancer

31. Error estimation and error bounding in energy norm based on a displacement recovery technique

32. Equilibrated patch recovery for accurate evaluation of upper error bounds in quantities of interest

33. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

34. Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

35. Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

36. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients

Catalog

Books, media, physical & digital resources